Zurueck zur Suche

Reporte zur Charge U7648AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

23Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
VA 5 TX 3 KY 2 GA 2 MS 1 NC 1 NJ 1 IN 1 NE 1 NY 1 IA 1 OH 1

VAERS 2660596

SANOFI PASTEUR · TDAP (ADACEL) · Charge u7648aa

kritisch
Staat
-
Alter
27,0
Geschlecht
F
Eingang
25.07.2023
Impfdatum
29.04.2023
Beginn
24.07.2023
Tage bis Beginn
86,0
Dosis
N/A
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Alanine aminotransferase normal Anion gap Aspartate aminotransferase normal Bacterial test positive Bilirubin urine Blood albumin normal Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium normal Blood chloride normal Blood creatinine increased Blood glucose normal Blood ketone body absent Blood pH increased Blood potassium normal Blood sodium normal Blood urea normal

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on July 25, 2023 06:47 Verified By: MD on July 25, 2023 06:47 Encounter Info: Hospital, Observation, 07/24/23 - * Final Report * Chief Complaint Flank pain History of Present Illness/Subjective 27-year-old female with past medical history of drug use, depression, diabetes mellitus, recent subarachnoid hemorrhage and E. coli bacteremia due to pyelonephritis presents with urgency and pain on urination for 3 days. The patient was admitted here for 5 days and discharged on July 11, at that time she was discharged to complete a prolonged course of cefpodoxime for which she states compliance. Prior history -Patient was admitted in March 2023 and again in April 2023. History of E. coli UTI with resistance, bacteremia. -Patient was then admitted from 4/29 to 5/3 after a fall. She was at OSH found to be in DKA, AKI and bilateral subarachnoid hemorrhage. She was transferred and treated for E. coli bacteremia due to bilateral pyelonephritis. ID was consulted. She was recommended to get IV ceftriaxone for 7 days and switch to cefpodoxime to finish total of 10 days of antibiotics. However she left AMA on fifth day of ceftriaxone. ? Neurosurgery was consulted during the hospital stay for the subarachnoid hemorrhage and recommended conservative management. Okay for chemical DVT prophylaxis Flank pain, dysuria, chills. She has history of using meth but denies any IV drugs Recently seen by urology, suspected etiology for recurrent pyelonephritis not related to structural abnormality, instead, diabetes. At this time, mild leukocytosis, mildly elevated creatinine, normal LFTs, blood sugar only 121, pregnancy test negative, urine was obtained that showed trace bacteria, nitrite positive, l leukocyte esterase positive, however, there were many squamous epithelial cells this is test is not reliable. Review of Systems Complains of flank pain, urinary frequency, dysuria, no fever or chills, remaining 10 point review of systems negative except as noted above. Otherwise, sleepy, somewhat unenthusiastic about cooperating. She apparently refused Tylenol in the emergency department. She actually would only provide very brief answers and was very disinterested, the above is as reliable as we can hope Physical Exam/Objective Vitals & Measurements most recent past 24 hours T: 37 ?C (Oral) TMIN: 36.8 ?C (Oral) TMAX: 37 ?C (Oral) BP: 98/71 HR: 97 (Monitored) RR: 14 SpO2: 99% Oxygen Therapy: Room air Oxygen Flow Rate: 0 (L/min) WT: 66 kg BMI: 25 Hemodynamics Neurologic Glasgow Coma Score: 15 Patient Weight Current Daily Weight: 66 kg 07/25/23 Previous Daily Weight: 68.1 kg 07/25/23 Difference from Previous: -2.100000 kg BMI: 25 07/25/23 Overweight (BMI 25-29.9) Patient Height Current Height: 165.1 cm 07/25/23 Constitutional: No acute distress nontoxic Eyes: PERRLA, normal conjunctiva ENMT: Moist oral mucosa Neck: Supple, non-tender, intact range of motion Respiratory: Lungs CTAB Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, non-tender, non-distended Musculoskeletal: No joint swelling, no deformity, intact ROM Integumentary: Intact, warm, dry no rashes Neurologic: Alert & Oriented x 3, no focal deficits Assessment/Plan 1. Recurrent pyelonephritis N12 Given resistance patterns and failure of treatment with beta-lactam, we will continue gentamicin. Follow urine cultures and blood cultures. While tachycardic, technically does not meet SIRS criteria. Additionally, hemodynamically stable and hypertensive. IV fluids. Monitor hemodynamics closely. 2. Intellectual disability F79 Noted 3. DM (diabetes mellitus), type 1, uncontrolled E10.65 Basal and bolus insulin, diabetic diet, Accu-Cheks 4. IDA (iron deficiency anemia) D50.9 Supplemental iron Lovenox for anticoagulation Full code Code Status Full Code Chronic Problem List Bacteremia Biliary dyskinesia Depression DM (diabetes mellitus), type 1, uncontrolled Dysfunctional uterine bleeding Folliculitis Genital herpes Genital herpes in women Heavy menses IDA (iron deficiency anemia) Intellectual disability Long term use of drug Low back pain Low back pain syndrome Nausea Pyelonephritis Recurrent genital herpes Recurrent pyelonephritis Recurrent UTI Right knee pain Screen for STD (sexually transmitted disease) Sepsis Severe sepsis without septic shock Unstable type 1 diabetes mellitus UTI (urinary tract infection) Procedure/Surgical History ?lap tuball ligation (04/23/2018) ?Cesarean section (2014) ?Tooth extraction (2013) Surgical History Internal 08/12/2019 Hysteroscopy Diagnostic DO 09/19/2018 Cholecystectomy Laparoscopic MD 04/23/2018 Tubal Clips Laparoscopic DO Medications Home Medications (24) Active Accu-Chek Guide Blood Glucose Meter Not Applicable, Other, Unscheduled Accu-Chek Guide Test Strips Check up to 4 times daily, Other, Unscheduled Accu-Chek Softclix Lancets Check up to 4 times daily, Other, Unscheduled, Dispense QS 90 days acetaminophen 325 mg oral tablet 650 mg = 2 Tablet, PRN, Orally, Q4H Ascensia Bayer Blood Glucometer Elite XL Not Applicable, Other, Unscheduled Ascensia Bayer Blood Glucometer Elite XL Not Applicable, Other, Unscheduled BD Ultra-Fine Nano (4mm x 32G) Pen Needle Use 4 per day, Other, Unscheduled, Pen Needlesuse with insulin BD Ultra-Fine Nano (4mm x 32G) Pen Needle Use 4 per day, Other, 4 Times Daily, Dispense QS for 30 days cefPODOXime 200 mg oral tablet 200 mg = 1 Tablet, Orally, BID ferrous sulfate 325 mg (65 mg elemental iron) oral tablet 325 mg = 1 Tablet, Orally, Daily FreeStyle Libre 2 Glucose Reader Not Applicable, Other, Unscheduled, E10.65 FreeStyle Libre 2 Sensors Use As Directed, Misc, Unscheduled, E10.65 gabapentin 100 mg oral capsule , TAKE 2 CAPSULES THREE TIMES DAILY FOR 3O DAYS Glucometer Elite Test Strips Check up to 4 times daily, Other, Unscheduled, Dispense QS 90 days insulin glargine 100 units/mL subcutaneous solution 42 Units, Subcutaneous, Daily Ketostix Reagent Strips In Foil See Instructions, Use as Directed Other Unscheduled Lancets Check up to 6 times daily, Other, Unscheduled, Dispense QS 90 days nitrofurantoin macrocrystals 100 mg oral capsule 100 mg = 1 Capsule, Orally, Daily NovoLOG (insulin aspart) FlexPen 100 units/mL subcutaneous solution See Instructions, subcutaneous for 30 days paliperidone 3 mg oral tablet, extended release , TAKE 1 TABLET BY MOUTH DAILY IN THE MORNING prazosin 1 mg oral capsule , TAKE 1 CAPSULE BY MOUTH AT BEDTIME promethazine 25 mg oral tablet 25 mg = 1 Tablet, PRN, Orally, Q6H Syringes - Insulin 1/2 mL See Instructions, Use 3 time daily with Humalog. Please dispense 6 mm, 1/2 mL insulin syringes x 90 days. VALAcyclovir 500 mg oral tablet Active Scheduled Inpatient Medications None Reported One-Time Medications Given 07/24/23 00:00:00 TO 07/25/23 06:47:33 acetaminophen (Tylenol), Tablet, 1,000 mg, Orally, ONCE, Ordered NOT yet givengentamicin, Injection, 300 mg, IVPB, ONCE, (1 DOSE 07/25/23 01:10:00) Lactated Ringers (LR - ED Bolus), Infusion, 1,000 mL, IVPB, ONCE, (1 DOSE 07/25/23 00:18:00) PRN Medications (0600 - 0559) from 07/24 - 07/25 None Reported Allergies NKA Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use 1-25 inhales/day. Substance Abuse Past, Methamphetamines Tobacco Tobacco Use: Former smoker, quit more than 30 days ago. Family History Hypertension: Mother. Lab Results All Labs Last 24 hours (No Micro or Pathology) Chemistry: Sodium SerPl QN: 142 mmol/L (07/24/23 20:16:00) Potassium SerPl QN: 4.4 mmol/L (07/24/23 20:16:00) Chloride SerPl QN: 104 mmol/L (07/24/23 20:16:00) Carbon Dioxide SerPl QN: 27 mmol/L (07/24/23 20:16:00) Anion Gap: 11 mmol/L (07/24/23 20:16:00) BUN SerPl QN: 12 mg/dL (07/24/23 20:16:00) Creatinine SerPl QN: 1.24 mg/dL High (07/24/23 20:16:00) Estimated GFR (CKD-EPI, no race): 61 mL/min/1.73m2 (07/24/23 20:16:00) Estimated CRCL (CG): 66 mL/min (07/24/23 20:16:00) Glucose SerPl QN: 121 mg/dL High (07/24/23 20:16:00) Calcium Total SerPl QN: 9.5 mg/dL (07/24/23 20:16:00) Alkaline Phos SerPl QN: 85 Units/L (07/24/23 20:16:00) ALT SerPl QN: 9 Units/L (07/24/23 20:16:00) AST SerPl QN: 18 Units/L (07/24/23 20:16:00) Bilirubin Total SerPl QN: 0.3 mg/dL (07/24/23 20:16:00) Total Protein SerPl QN: 7 GM/dL (07/24/23 20:16:00) Albumin SerPl QN: 3.6 GM/dL (07/24/23 20:16:00) Ketones SerPl QN: Negative (07/24/23 22:57:00) pH Bld Venous QN: 7.6 High (07/24/23 20:16:00) Patient Temperature: 37 DegC (07/24/23 20:16:00) Urine Studies: Pregnancy Test Urine: Negative (07/24/23 20:24:00) Color: Light-Yellow (07/24/23 20:24:00) Clarity: Cloudy (07/24/23 20:24:00) Specific Gravity: 1.006 (07/24/23 20:24:00) pH: 6 (07/24/23 20:24:00) Protein: 70 Abnormal (07/24/23 20:24:00) Glucose: 150 Abnormal (07/24/23 20:24:00) Ketones: NEGATIVE (07/24/23 20:24:00) Bilirubin: NEGATIVE (07/24/23 20:24:00) Hgb Ur: Large 3+ Abnormal (07/24/23 20:24:00) Nitrite: Positive 1+ Abnormal (07/24/23 20:24:00) Urobilinogen: Normal (07/24/23 20:24:00) Leukocyte Esterase Ur: Large500 Abnormal (07/24/23 20:24:00) WBC: >100 Abnormal (07/24/23 20:24:00) RBC: 51-100 Abnormal (07/24/23 20:24:00) WBC Clumps: PRESENT. Abnormal (07/24/23 20:24:00) Bacteria: TRACE. (07/24/23 20:24:00) Squamous Epithelial: Many (07/24/23 20:24:00) Diagnostics Radiology Results - Last 24 hours Across Visits No radiology results found in the last 24 hours. Signature Line Electronically Signed on 07/25/23 06:47 ________________________________________________________ MD

Weitere VAERSDATA-Felder
Praegender Schweregrund
Coma scale
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2648670

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

schwer
Staat
MS
Alter
12,0
Geschlecht
F
Eingang
22.06.2023
Impfdatum
07.06.2023
Beginn
07.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Eye movement disorder Loss of consciousness

Symptomtext

Tdap and MenQuadfi given in R arm IM. HPV9 given IM in L arm. Patient sitting on table then moved to chair to sit but sister. Patient then stated within 2 minutes of last vaccine (HPV9) that she felt like she would pass out. Patient passed out on her sisters shoulder mom then picked her head up and childs eyes tolled back. The Dr. came in and laid child down on seat and monitored her for at least the next hour. Once patient felt ok, water given and family helped child to restroom and then left office. Nurse from our office called mom next day was doing better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Cough
Vorgeschichte
Asthma, Depression, Anxiety
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2634528

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

schwer
Staat
NC
Alter
41,0
Geschlecht
M
Eingang
19.05.2023
Impfdatum
25.04.2023
Beginn
25.04.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Chromaturia Fatigue Mobility decreased Muscular weakness Pyrexia Syncope

Symptomtext

Patient is a hospital worker who was due for a Tdap booster. He had tolerated Tdap previously with no adverse event, and consented to receive the Tdap booster during a routine annual employee wellness visit. The vaccine was given around 2:30 PM on 4/25/23 with no immediate reaction or concerns, and the patient returned home. However, approximately 7 hours post-dose (at about 9:30 PM) patient developed severe chills and muscle weakness. These symptoms quickly progressed and within 20 minutes the patient collapsed. He could move his limbs but did not have the strength to stand and walk. Patient remained laying for about 90 minutes, at which point he gathered sufficient strength to walk and get assistance. His temperature at that time was measured at 102.8 F. Patient was given aspirin 325 mg, acetaminophen 1000 mg and ketorolac 10 mg with no reduction in fever or symptoms. He finally defervesced below 100.8 F at approximately 9 hours from symptom onset (around 6:30 AM on 4/26/23) after a dose of ibuprofen 800 mg was given. Patient required scheduled doses of ibuprofen, acetaminophen and aspirin to maintain temperature below 100.8 F for approximately 36 hours from symptom onset. During this time, muscle weakness and fatigue continued and patient's urine was dark. Urine color returned to normal at approximately three days post-dose, at which point all symptoms appeared to be resolved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension, anxiety
Andere Medikamente
Patient not taking any prescription medications. Has taken the following supplements for at least the past 5 years: 1) zinc picolinate 15 mg PO daily 2) vitamin B6 25 mg PO daily 3) borage oil 1000 mg PO daily 4) probiotic 1 capsule PO dail
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2603441

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

moderat
Staat
NJ
Alter
53,0
Geschlecht
M
Eingang
24.03.2023
Impfdatum
23.01.2023
Beginn
24.01.2023
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Antinuclear antibody negative Blood folate abnormal Blood iron normal Blood magnesium normal Blood thyroid stimulating hormone normal Burning sensation Bursitis Chest pain Differential white blood cell count abnormal Facial pain Full blood count abnormal Headache Hypoaesthesia Iron binding capacity total normal Magnetic resonance imaging normal Metabolic function test Paraesthesia Platelet count abnormal

Symptomtext

chest pain, bursitis in the left arm, bad headaches, pain in the left side of face, numbness, burning and tingling in the extremities

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
MRI 3/7/2023 nml 3/6/2023 vitamin B12/folate, serum panel ABNORMAL comprehensive metabolic panel UNKNOWN magnesium NORMAL TSH+free T4 NORMAL vitamin D,25-oh,total,ia NORMAL CBC (includes diff/plt) ABNORMAL iron, TIBC and ferritin panel NORMAL ANA multiplex w/reflex 11 Ab cascade NORMAL
Aktuelle Erkrankungen
Knee pain
Vorgeschichte
Adjustment disorder w/mixed anxiety and depressed mood
Andere Medikamente
None
Allergien
Aspirin, penicillins
Vorherige Impfungen
-

VAERS 2574239

SANOFI PASTEUR · DTAP (DAPTACEL) · Charge U7648AA

moderat
Staat
IN
Alter
53,0
Geschlecht
F
Eingang
02.02.2023
Impfdatum
24.01.2023
Beginn
24.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Injection site pain Injection site swelling X-ray limb normal

Symptomtext

Pain to right upper arm started shortly after vaccine was administered. Progressively worsening pain and swelling to right upper arm and right shoulder since onset. Reports reduced range of motion to right arm due to pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
1/27/2023 X-rays of right shoulder, preliminary result per provider: normal study
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Norvasc; Levothyroxine
Allergien
Claritin
Vorherige Impfungen
-

VAERS 2636889

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

mild
Staat
GA
Alter
37,0
Geschlecht
F
Eingang
25.05.2023
Impfdatum
22.05.2023
Beginn
23.05.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Injection site rash Injection site warmth

Symptomtext

Rash started@ site of injection approximately 24 hours afterward. Today, 72 hours after injection right upper arm has rash approximately 7cm x 4 cm and feels hot to touch and is painful. Patient was seen by her PCP Dr. and was prescribed Doxycycline. She was advised to follow up with urgent care or ER if her symptoms worsened,

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
serum negative arthritis
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2630607

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

mild
Staat
NE
Alter
24,0
Geschlecht
F
Eingang
11.05.2023
Impfdatum
11.05.2023
Beginn
11.05.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain upper Back pain Fatigue Feeling of body temperature change Headache Nausea Pyrexia

Symptomtext

5/10/2023: Said employee contacted Employee Health late morning reporting onset of the following symptoms occurring on 5/9/2023: Nausea followed by two episodes of vomiting at 2030 & 2330. Approximately at midnight, a sensation of freezing followed by feeling hot with reported low-grade temperature of 99. On the mornng of the phone call (5/10/2023) stated, other symptoms included; "headache, stomach hurting and lower back, fatifue". Denies diarrhea. She reporte starting to drink eater and eating some bread. Dened fever at time of phone call, and, denied respiratory symptoms that may be associated with COVID-19 illness. Advised to drink clear fluids and foods such as toast, crackers, jello. Acknowledged understanding. 5/10/2023: 1728: Update. Employoee called reporting a fever of 101 at noon, having taken Tylenol. Stated she is "feeling better". Reviewed CDC, VIS givento employee prior to administration of Tdap, correllating the potential for vaccine reaction. Plan: Follow up with phone call on 5/11/2023. 5/11/2023: Emplyee Health, reporter of the adverse reaction contacted VAERS to review employee symptoms. It was disclosed that medical advice could not be given, but, encouraged to complete adverse reaction report. 0945: Employee Health consulted with PA regarding events. It is undetermined if this is a vaccine reaction or other illness. 1430: Consulted with Pharmacy Staff regarding event. It was discussed that in the future, when the said employee needs to be boosted that she could recieve a Td booster.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain upper
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
Non-Drowsy Allergy Relief Pri-ntec Pre-biotic gummy Multi-vitamin
Allergien
Prednison Ceclor Bactrim
Vorherige Impfungen
-

VAERS 2597564

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

mild
Staat
KY
Alter
61,0
Geschlecht
F
Eingang
16.03.2023
Impfdatum
10.03.2023
Beginn
10.03.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Injection site swelling Nodule Pain Rash

Symptomtext

EVENT: LARGE AREA OF SWELLING AT INJECTION SITE WITH RASH ON ARM. TREATMENT: rec'd shot of dexamethasone 4mg/ml inj solution & RX of Methylprednisolone 4mg dose pack 21 OUTCOME: 03/16/2023 Lg knot going down, soreness leaving and rash /redness is better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
Penicillin, fish, adhesive in bandages
Vorherige Impfungen
-

VAERS 2596332

SANOFI PASTEUR · DTAP (DAPTACEL) · Charge U7648AA

mild
Staat
NY
Alter
62,0
Geschlecht
F
Eingang
14.03.2023
Impfdatum
10.03.2023
Beginn
11.03.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site irritation Injection site pain Injection site pruritus Injection site swelling

Symptomtext

Pt presented in Office complaining of upper L arm soreness, irritation, redness, itchiness, and site being swollen. Started 3/11/23 Pt took Ibuprofen 600MG, used topical ointments like Triple antibiotic ointment, Tiger Balm ointment as well as Naproxen 1tab Took these medication in a span of 3/11-3/14 (4 days) w/ no relieve. Hasn't helped PT at all.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
NONE
Vorgeschichte
Isolated Cervical Dystonia Dyslipidemia
Andere Medikamente
Lexapro 5MG Daily Rosuvastatin 5MG Daily Rizatriptan 5MG PRM for Migraine Headaches Onabotulinumtoxin A Q90 Days
Allergien
Dust
Vorherige Impfungen
-

VAERS 2595510

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

mild
Staat
IA
Alter
12,0
Geschlecht
M
Eingang
13.03.2023
Impfdatum
24.02.2023
Beginn
26.02.2023
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain Urticaria

Symptomtext

Two days after administration, patient developed a 8-10 cm wheel on his arm and experienced pain. Parents administered Benadryl, and it was gone by the next day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None that we are aware of at clinic
Vorgeschichte
None noted
Andere Medikamente
Possibly Loratadine 10 mg
Allergien
No Known Drug Allergies
Vorherige Impfungen
-

VAERS 2587283

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

mild
Staat
VA
Alter
53,0
Geschlecht
M
Eingang
24.02.2023
Impfdatum
21.02.2023
Beginn
21.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Chills Decreased appetite Dry throat Fatigue Fear Headache Hyperacusis Loss of personal independence in daily activities Malaise Muscle twitching Myalgia Throat irritation

Symptomtext

severe persistent deep muscle (almost like bone) ache, headache, chills so bad scared to even take a hot shower,, low grade fever (100.1 max), malaise, fatigue, joint ache, intermittent sharp muscle twinges, absolute loss of appetite, dry cracked throat, aversion to sound. unable to perform basic activities of daily living......taking motrin 600 - 800mg three times a day, this is the third day........horrible horrible experience i believe from the shingles vaccine. had the tdap vaccine in the past without any issues.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
gerd
Andere Medikamente
nexium
Allergien
none
Vorherige Impfungen
-

VAERS 2717531

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

gering
Staat
TX
Alter
16,0
Geschlecht
F
Eingang
24.11.2023
Impfdatum
10.11.2023
Beginn
10.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

16 year old patient was given an extra dose of ADACEL with no reported adverse event; Initial information received on 13-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 16 years old female patient was given an extra dose of Diphtheria-2/Tetanus/5 AC Pertussis vaccine [Adacel] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Meningococcal vaccine A/C/Y/W CONJ (TET TOX) (Menquadfi) for Prophylactic vaccination. On 10-Nov-2023, the patient received an unknown extra dose of suspect Diphtheria-2/Tetanus/5 AC Pertussis vaccine Suspension for injection of lot U7648AA and expiry: 15-Feb-2025 via unknown route in unknown administration site for immunization; with no reported adverse event (extra dose administered) (latency: same day). No lab data was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
MENQUADFI
Allergien
-
Vorherige Impfungen
-

VAERS 2714702

SANOFI PASTEUR · TDAP (ADACEL) · Charge u7648aa

gering
Staat
TX
Alter
16,0
Geschlecht
F
Eingang
16.11.2023
Impfdatum
10.11.2023
Beginn
10.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

Medical Assistant when she was inputting the vaccine information in the patient chart she realized that she gave the 16 yr old patient the Tdap instead of the Menb. She informed the provider and the practice manager, the provider called the mother to informed her of the incident.Patient is doing well with no reaction to the vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
NKDA
Vorgeschichte
NKDA
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2679146

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

gering
Staat
OH
Alter
71,0
Geschlecht
F
Eingang
05.09.2023
Impfdatum
23.08.2023
Beginn
23.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product administered to patient of inappropriate age

Symptomtext

they administered ADACEL to a 71-year-old patient with no reported adverse event; Initial information received on 28-Aug-2023 regarding an unsolicited valid non-serious case received via pharmacist. This case involves, administered diphtheria-2/tetanus/5 AC pertussis vaccine [Adacel] to a 71-year-old patient with no reported adverse. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included influenza vaccine INACT SPLIT 3V (Fluzone High Dose) for Prophylactic vaccination. On 23-Aug-2023, the patient received 0.5 ml dose of suspect diphtheria-2/tetanus/5 AC pertussis vaccine Suspension for injection (strength: unknown) (lot: U7648AA, Expiry date: 15-Feb-2025) via intramuscular route in the right deltoid for Immunization and they administered adacel to a 71-year-old patient with no reported adverse event (product administered to patient of inappropriate age) (latency: same day) following the administration of diphtheria-2/tetanus/5 AC pertussis vaccine. Action taken with diphtheria, tetanus and acellular pertussis vaccine (Adacel) was not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
FLUZONE HIGH DOSE
Allergien
-
Vorherige Impfungen
-

VAERS 2662698

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

gering
Staat
GA
Alter
11,0
Geschlecht
F
Eingang
28.07.2023
Impfdatum
28.07.2023
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Unevaluable event

Symptomtext

None

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2633961

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

gering
Staat
MI
Alter
12,0
Geschlecht
F
Eingang
18.05.2023
Impfdatum
18.05.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Inappropriate schedule of product administration

Symptomtext

Patient has two records with different last names. Mom has been told Numerous times to bring legal Documentation to combine records.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
Tdap, meningococcal & HPV were given on 5-13-22 & a second set was given today, 5-18-23. Mom was contacted about the incident & she was ok with it.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2626093

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

gering
Staat
KY
Alter
74,0
Geschlecht
M
Eingang
04.05.2023
Impfdatum
28.04.2023
Beginn
28.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product administered to patient of inappropriate age

Symptomtext

gave Adacel to an elderly patient with no reported adverse event; Initial information received on 28-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 74 years old male patient (59 kg) and it was reported Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel] was given to an elderly patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 28-Apr-2023, the patient received 0.5 ml of suspect Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine Suspension for injection (lot number: U7648AA, Expiry date: 15-Feb-2025) (Frequency-once; Strength: Standard) via intramuscular route in the right deltoid for immunization. On 28-Apr-2023, it was reported Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel] was given to an elderly patient with no reported adverse event (product administered to patient of inappropriate age) (Latency: same day). It was reported, Caller, a pharmacist intern, stated he has a clinical question about Adacel. Caller stated they gave Adacel to an adult more than 130 pounds with a 5/8th inch needle. Caller asked if the vaccine would be effective for tetanus and diptheria or would the patient need revaccination. Caller states that ADACEL was administered to a patient intramuscular in the right deltoid but was administered with a 5/8th inch needle. They are inquiring if this dose be counted as valid. Action taken: not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2622472

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

gering
Staat
TX
Alter
4,0
Geschlecht
M
Eingang
27.04.2023
Impfdatum
27.04.2023
Beginn
27.04.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

No signs or Symptoms

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
Fragile X Syndrome
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2622179

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

gering
Staat
-
Alter
1,3
Geschlecht
F
Eingang
27.04.2023
Impfdatum
19.04.2023
Beginn
19.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

Patient's mother did not want child to have a multi-dose injection. Provider told nursing staff it was ok to give Tdap being that she already has had a tetanus dose in the past. Nursing staff asked to verify if this was correct. Provider ordered vaccine and vaccine was given. Patient's mother was notified that this vaccine is for 7 years and older and mother stated it was ok. No treatment/outcomes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2584487

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

gering
Staat
VA
Alter
-
Geschlecht
M
Eingang
21.02.2023
Impfdatum
09.02.2023
Beginn
09.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Poor quality product administered Product storage error

Symptomtext

ADACEL being administered post excursion and to an individual less than 10 years of age with no reported adverse event; temperature excursion involving unopened ADACEL,The condition was 48.9F for 7 days due to a refrigerator malfunction with no reported adverse event; Initial information received on 13-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2023SA052418. This case involves a 9 years old male patient who experienced temperature excursion involving unopened adacel,the condition was 48.9f for 7 days due to a refrigerator malfunction with no reported adverse event and adacel being administered post excursion and to an individual less than 10 years of age with no reported adverse event after receiving vaccine diphtheria-2/tetanus/5 ac pertussis vaccine [adacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included IPOL. On 09-Feb-2023, the patient received a booster 0.5 ml once of suspect diphtheria-2/tetanus/5 ac pertussis vaccine Suspension for injection lot U7648AA via intramuscular route in (unknown strength, expiration date) Right deltoid for Immunization. On 09-Feb-2023 the patient developed a non-serious temperature excursion involving unopened adacel, the condition was 48.9f for 7 days due to a refrigerator malfunction with no reported adverse event (product storage error) (latency: same day) On an unknown date the patient developed a non-serious adacel being administered post excursion and to an individual less than 10 years of age with no reported adverse event (poor quality product administered) (latency: same day). Reported a temperature excursion involving unopened ADACEL, TENIVAC and MENQUADFI and is requesting stability information. The condition was 48.9F for 7 days due to a refrigerator malfunction on 3FEB2023 (not human error). None of the products were supported by the extended stability data. Reporter also reports that 4 ADACEL doses were administered after the excursion. Lab data not reported. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the events (temperature excursion involving unopened ADACEL,The condition was 48.9F for 7 days due to a refrigerator malfunction with no reported adverse event, ADACEL being administered post excursion and to an individual less than 10 years of age with no reported adverse event). At time of reporting, the outcome was Unknown for the event temperature excursion involving unopened adacel,the condition was 48.9f for 7 days due to a refrigerator malfunction with no reported adverse event and was Unknown for the event adacel being administered post excursion and to an individual less than 10 years of age with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
IPOL
Allergien
-
Vorherige Impfungen
-

VAERS 2583324

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

gering
Staat
VA
Alter
48,0
Geschlecht
M
Eingang
17.02.2023
Impfdatum
07.02.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Poor quality product administered Product storage error

Symptomtext

temperature excursion involving unopened adacel, tenivac and menquadfi and the condition was 48.9f for 7 days due to a refrigerator malfunction with no reported adverse event; ADACEL being administered post excursion with no reported adverse event; Initial information received on 13-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2023SA052418(CLUSTER). This case involves a 48 years old male patient to whom Diphtheria-2/tetanus/5 ac pertussis vaccine [adacel] being administered post excursion with no reported adverse event and temperature excursion involving unopened Meningococcal a-c-y-w135 (t conj) vaccine [Menquadfi], diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] and diphtheria-2/tetanus/5 ac pertussis vaccine [adacel] and the condition was 48.9f for 7 days due to a refrigerator malfunction with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, Diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult and meningococcal a-c-y-w135 (t conj) vaccine (formulation, strength, lot number and expiry date were not reported) temperature excursion occured and the condition was 48.9f for 7 days due to a refrigerator malfunction with no reported adverse event (product storage error) On 07-Feb-2023, the patient received a suspect Diphtheria-2/tetanus/5 ac pertussis vaccine Suspension for injection at dose of 0.5 ml (strength not reported) ( lot U7648AA and expiry date- 15-Feb-2025) via intramuscular route in the left deltoid for immunization post excursion with no reported adverse event (poor quality product administered). Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2582706

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

gering
Staat
VA
Alter
49,0
Geschlecht
F
Eingang
16.02.2023
Impfdatum
06.02.2023
Beginn
06.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Poor quality product administered

Symptomtext

ADACEL being administered post excursion with no reported adverse event; Initial information received on 13-Feb-2023 regarding an unsolicited valid non-serious case received via health professional. Agency number: 01489354 This case involves 49 years old female patient to whom Diphtheria-2/Tetanus/5 AC Pertussis Vaccine [Adacel] being administered post excursion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. This case is linked to cases 2023SA051850, 2023SA051621 and 2023SA052675. It was reported that "Caller reported a temperature excursion involving unopened Adacel, Tenivac and Menquadfi and was requesting stability information. The condition was 48.9F for 7 days due to a refrigerator malfunction on 3-Feb-2023 (not human error). None of the products were supported by the extended stability data. Caller also reports that 4 Adacel doses were administered after the excursion." On 06-Feb-2023, the patient received booster dose suspect Adacel vaccine at 0.5ml once (lot: U7648AA, expiration: 15-Feb-2025) via intramuscular route in the left deltoid for Immunization being administered post excursion with no reported adverse event (poor quality product administered) at same day latency. This situation is reported as a medication error due to ADACEL being administered post excursion. Action taken with ADACEL vaccine was not applicable. At time of reporting, the outcome was Unknown for the event poor quality product administered. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2582705

SANOFI PASTEUR · TDAP (ADACEL) · Charge U7648AA

gering
Staat
VA
Alter
42,0
Geschlecht
F
Eingang
16.02.2023
Impfdatum
09.02.2023
Beginn
09.02.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Poor quality product administered Product storage error

Symptomtext

condition was 48.9F for 7 days due to a refrigerator malfunction on 3-Feb-2023 with no reported adverse event; Adacel was administered post excursion with no reported adverse event; Initial information received from on 13-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 42 years old female patient and it was reported that condition was 48.9f for 7 days due to a refrigerator malfunction on 3-feb-2023 and diphtheria-2/tetanus/5 AC pertussis vaccine [Adacel] was administered post excursion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitants and family history were not provided. It was reported that the condition was 48.9f for 7 days due to a refrigerator malfunction on 3-feb-2023 with no reported adverse event (product storage error) and on 09-Feb-2023, a dose of 0.5 ml (1X) of suspect diphtheria-2/tetanus/5 AC pertussis vaccine [Adacel] suspension for injection (batch/lot number: U7648AA and expiry date: 15-feb-2025; strength: unknown) was administered via intramuscular route in the left deltoid for immunization post excursion with no reported adverse event (poor quality product administered) (latency: same day). Action taken: Not applicable. At time of reporting, the outcome was Unknown for the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01489250: 01489329: 01489354:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-